Clinical trial
A Breath-based Naltrexone Adherence Tool to Manage Narcotic-addicted HIV Patients.
NCT02194764 is registered in ClinicalTrials.gov with Xhale Assurance as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Breath-based Naltrexone Adherence Tool to Manage Narcotic-addicted HIV Patients.
- Lead sponsor
- Xhale Assurance
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- July 31, 2014
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy adults